LOVAZA (omega-3-acid ethyl esters) – a combination of ethyl esters of omega 3 fatty acids, principally EPA and DHA commonly used to elevated triglyceride (TG) levels. The mechanism of action of Lovaza is not completely understood. Potential mechanisms of action include inhibition of acyl-CoA:1,2-diacylglycerol acyltransferase, increased mitochondrial and peroxisomal beta-oxidation in the liver, decreased lipogenesis […]
TRICOR (fenofibrate) – a peroxisome proliferator receptor alpha (PPARα) activator commonly used to treat certain lipid disorders. FDA approved uses: TriCor is indicated as an adjunct to diet – To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia; For treatment of adult […]
ZETIA (ezetimibe) – an inhibitor of intestinal cholesterol (and related phytosterol) absorption commonly used to certain types of hyperlipidemias. Specifically, Ezetimibe works to reduce blood cholesterol by inhibiting the absorption of cholesterol by the small intestine. FDA approved uses: Zetia is as an adjunct to diet to: Reduce elevated total-C, LDL-C, Apo B, and non-HDL-C […]
LOVENOX (enoxaparin) – a low molecular weight heparin commonly used in clinical settings where anticoagulation is needed. Low molecular weight heparins exert their clinical effect through the antithrombotic properties of heparins. FDA approved uses: Lovenox is indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical […]